NEVRO CORP (NVRO)

Company Profile

Nevro Corp. engages in the development of medical devices. The company is headquartered in Redwood City, California and currently employs 1,087 full-time employees. The company went IPO on 2014-11-06. The firm is focused on delivering life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. The firm has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza HFX iQ platform. Its HFX solution delivers a versatile range of waveforms, including its paresthesia-free 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain. The firm's products include Senza II SCS System, Senza Omnia SCS System, Senza Omnia upgrade, Omnia Powered by HFX Connect, Senza HFX iQ System, Surpass Surgical Lead and Reduced-size Surpass-C Surgical Lead. The firm is also focused on a minimally invasive treatment option for patients suffering from chronic sacroiliac joint (SI Joint) pain.

Company Info

NEVRO CORP

1800 Bridge Parkway

Redwood City CALIFORNIA 94065

P: 16502510005

CEO: D. Keith Grossman

Employees: 1087

Website: https://www.nevro.com